Business Context and Reporting Period
This Form 6-K filing by Redhill Biopharma Ltd. is dated September 21, 2015. The document serves as a convenience translation of a notice published in Israeli newspapers regarding the Company's Annual General Meeting of Shareholders. The filing does not contain financial results for a specific reporting period but rather administrative details for the upcoming shareholder meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural notice and does not include financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document references the discussion of financial statements as of December 31, 2014, as an agenda item for the upcoming meeting, but does not disclose the content of those statements.
Guidance, Outlook, and Corporate Actions
The primary content of this filing concerns the scheduling and agenda of the Annual General Meeting:
- Meeting Date: Thursday, October 29, 2015, at 3:00 p.m. Israel time.
- Location: Company offices at 21 Ha'arba'a Street, Floor 16, Tel Aviv.
- Key Agenda Items:
- Discussion of financial statements as of December 31, 2014.
- Appointment of Kesselman & Kesselman (PricewaterhouseCoopers International Limited) as auditors for 2015.
- Re-election of Mr. Eric Swenden and Dr. Kenneth Reed to the Board of Directors.
- Record Date: Friday, September 25, 2015.
- Proxy Materials: U.S. proxy solicitation materials were expected to be furnished separately on or about September 30, 2015.
Key Facts for Investor Verification
- Verify the outcome of the auditor appointment and board re-elections at the October 29, 2015 meeting.
- Review the financial statements for the year ended December 31, 2014, which are scheduled for discussion but not included in this filing.
- Confirm the receipt of the separate U.S. proxy statement expected around September 30, 2015.
- Note that this filing is a translation of an Israeli legal notice and does not constitute a proxy solicitation in the United States.